Nicotinamide adenine dinucleotide precursors in human health and disease: a systematic review of clinical trials
Sharma C, Donu D, Cen Y
Published in Nutrients
Key Findings
Oral NAD precursors reliably raise blood NAD+ levels, but clinical trials have generally failed to show consistent functional benefits.
Conclusions
Biomarker change without demonstrated clinical outcomes.
Limitations
Heterogeneous precursors and endpoints.
Supplements Studied
Oral NAD precursors reliably raise blood NAD+ levels, but trials have failed to show consistent functional benefits.
Oral NAD precursors reliably raise blood NAD+ levels, but trials have failed to show consistent functional benefits.
Oral NAD precursors reliably raise blood NAD+ levels, but clinical trials have generally failed to show consistent functional benefits.
Outcomes Measured
NAD precursors raise blood NAD+ levels without consistent functional or energetic benefit.
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.